Endometriosis is the leading cause of unexplained infertility among individuals assigned female at birth.
Additionally, 50 to 65 percent of cases involving chronic pelvic pain are undiagnosed endometriosis.
Comparable to the diagnostic gold standard, laparoscopy, EndomiR offers rapid, accurate identification of endometriosis in those with chronic pelvic pain or infertility, ensuring timely intervention and enhancing the standard of care for women.
Consult physician
Blood sample
Test and analyze in lab
Results available to physician
Afynia’s diagnostic panel detects the expression levels of circulating microRNAs (miRNAs) that are differentially expressed in women with endometriosis versus symptomatic controls. EndomiR accurately detects endometriosis and delivers objective data for informed decision-making.
To learn more about EndomiR, please email us at info@afynia.com or phone at 1-888-829-2462.
Who is a candidate for testing?
EndomiR is indicated for use in women with chronic pelvic pain, menstrual pain, and/or unexplained infertility.
It is not indicated for use in women with or suspected reproductive cancers.
How can I gain access to the EndomiR blood test?
EndomiR is currently available for research-use only in fertility clinics in Canada. We are continually looking for the opportunity to connect with more clinics and expand our patient list.
If EndomiR is currently unavailable at your nearest clinic, share our website with them.
What do the results on my test indicate?
Your result will be shown as a percentage that represents your likelihood of having endometriosis compared to confirmed surgical controls. Your physician will follow up regarding next steps and treatment.